Vaso Corporation (VASO)
OTCMKTS: VASO · Delayed Price · USD
0.260
+0.010 (4.00%)
Jul 3, 2024, 12:34 PM EDT - Market closed
Vaso Corporation Market Cap
Vaso Corporation has a market cap or net worth of $45.58 million as of July 3, 2024. Its market cap has increased by 32.12% in one year.
Market Cap
45.58M
Enterprise Value
23.87M
1-Year Change
32.12%
Ranking
n/a
Category
Stock Price
$0.26
Market Cap Chart
Since December 1, 1998, Vaso Corporation's market cap has increased from $42.60M to $45.58M, an increase of 7.00%. That is a compound annual growth rate of 0.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2006 | 6.50M | -57.79% |
| Dec 30, 2005 | 15.40M | -71.74% |
| Dec 31, 2004 | 54.50M | -15.11% |
| Dec 31, 2003 | 64.20M | 18.67% |
| Dec 31, 2002 | 54.10M | -74.44% |
| Dec 31, 2001 | 211.70M | 71.56% |
| Dec 29, 2000 | 123.40M | 149.80% |
| Dec 31, 1999 | 49.40M | 41.14% |
| Dec 31, 1998 | 35.00M | -17.84% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 847.90B |
| Novo Nordisk | 622.30B |
| UnitedHealth Group | 450.56B |
| Johnson & Johnson | 350.56B |
| Merck & Co. | 318.63B |
| AbbVie | 289.79B |
| AstraZeneca | 238.12B |
| Novartis AG | 208.78B |